Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth

The regulatory microRNA miR-150 is involved in the development of hemopathies and is downregulated in T-lymphomas, such as anaplastic large-cell lymphoma (ALCL) tumors. ALCL is defined by the presence or absence of translocations that activate the anaplastic lymphoma kinase (ALK), with nucleophosmin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Invest
Autors principals: Hoareau-Aveilla, Coralie, Valentin, Thibaud, Daugrois, Camille, Quelen, Cathy, Mitou, Géraldine, Quentin, Samuel, Jia, Jinsong, Spicuglia, Salvatore, Ferrier, Pierre, Ceccon, Monica, Giuriato, Sylvie, Gambacorti-Passerini, Carlo, Brousset, Pierre, Lamant, Laurence, Meggetto, Fabienne
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4588301/
https://ncbi.nlm.nih.gov/pubmed/26258416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI78488
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars